ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

MDNA Medicenna Therapeutics Corp

1,67
-0,06 (-3,47%)
18 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Medicenna Therapeutics Corp MDNA Toronto Common Stock
  Änderung Änderung % Aktuell Zeit
-0,06 -3,47% 1,67 22:01:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,73 1,67 1,77 1,67 1,73
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.4.202412:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
09.4.202422:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
09.4.202418:01GLOBEMedicenna Presents Updated Preclinical Data on MDNA113, a..
04.4.202413:00GLOBEMedicenna to Present at the 2024 Bloom Burton & Co...
06.3.202413:00GLOBEMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1..
14.2.202413:30GLOBEMedicenna Therapeutics Reports Third Quarter Fiscal 2024..
13.2.202413:00GLOBEMedicenna Announces First Patient Dosed in ABILITY-1 Study..
12.1.202423:36GLOBEMedicenna Announces Appointment of New Auditor
09.1.202413:00GLOBEMedicenna Commences Enrollment in the ABILITY-1 Study..
22.12.202301:30GLOBEMedicenna Extends Period to Exercise Certain Warrants
19.12.202313:00GLOBEMedicenna Announces Trading on the OTCQB Under the Symbol..
14.11.202314:30GLOBEMedicenna Therapeutics Reports Second Quarter Fiscal 2024..
09.11.202314:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
06.11.202313:00GLOBEMedicenna Announces Promising Single-Agent Response and..
03.11.202317:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27.10.202313:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25.10.202313:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24.10.202313:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10.10.202313:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03.10.202313:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
28.9.202323:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28.9.202313:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06.9.202313:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28.8.202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14.8.202313:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
08.8.202313:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04.8.202313:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01.8.202315:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28.7.202313:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25.7.202313:00GLOBEMedicenna Presents at National Brain Tumor Society's..
05.7.202313:00GLOBEMedicenna Extends Period to Exercise Certain Warrants
27.6.202314:00GLOBEMedicenna Reports Fiscal Year 2023 Financial Results and..
27.4.202313:00GLOBEMedicenna Granted 180-Day Extension to Meet Nasdaq Minimum..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock